Rare diseases
Investigational molecules
Locations
Back to Poland36 clinical trials in Malbork, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
PolandPhase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis
PolandA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
PolandStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
PolandPhase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)
PolandICP-332 for Adults with Prurigo Nodularis
PolandEvaluation of Long-Term Safety and Efficacy of Litifilimab in Adults with Active Systemic Lupus Erythematosus: A Phase 3 Multicenter, Randomized, Dose-Blind Study
PolandPhase 3 Randomized, Double‑Blind Study of Telitacicept versus Placebo for Efficacy and Safety in Adults with Active Primary Sjögren’s Disease
PolandStudy of telitacicept compared to placebo in adults with moderate to severe systemic lupus erythematosus
PolandEfficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
PolandEvaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
PolandA study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis
PolandThe busiest research cities in the country
What the registry says about research in the country
Studies focusing on various skin conditions including genital psoriasis, atopic dermatitis, and chronic hand eczema. Research evaluates new topical treatments and systemic therapies for improved patient outcomes.
Novel therapeutic approaches aim to address both symptoms and underlying causes of skin disorders.
Clinical investigations targeting conditions like Sjögren's Syndrome and lupus erythematosus. Research focuses on evaluating innovative treatments for managing systemic manifestations and improving quality of life.
Studies aim to develop targeted therapies for complex autoimmune conditions.
Research examining treatments for hypertriglyceridemia and gastroparesis. Studies evaluate medication efficacy for managing metabolic disorders and digestive system conditions.
Innovative approaches focus on improving patient outcomes in metabolic and digestive disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
